Submission Details
| 510(k) Number | K223511 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 22, 2022 |
| Decision Date | May 02, 2023 |
| Days to Decision | 161 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K223511 is an FDA 510(k) clearance for the Excella Navigation Instruments, a Orthopedic Stereotaxic Instrument (Class II — Special Controls, product code OLO), submitted by Innovasis, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on May 2, 2023, 161 days after receiving the submission on November 22, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 882.4560.
| 510(k) Number | K223511 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 22, 2022 |
| Decision Date | May 02, 2023 |
| Days to Decision | 161 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | OLO — Orthopedic Stereotaxic Instrument |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.4560 |
| Definition | Stereotaxic Guidance During Orthopedic Surgery Procedures. Indicated For Orthopedic Joint Or Spine Surgery. Neurological Stereotaxic Instruments Are Classified Under Product Code Haw. |